Dementia News and Research

Latest Dementia News and Research

Eli Lilly starts trial of treatment of mild to moderate Alzheimer's disease

Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.

1 Apr 2008

Middle-age spread a potent predictor of dementia

According to a new study overweight or obese people are at an increased risk of developing dementia or Alzheimer's disease.

31 Mar 2008

Study shows that a larger abdomen in midlife increases risk of dementia

People in their 40s with larger stomachs have a higher risk for dementia when they reach their 70s, according to a study published in the March 26, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology .

28 Mar 2008

Near-infrared light used to detect signs of Alzheimer's disease

A team of researchers in Bedford, Mass. has developed a way of examining brain tissue with near-infrared light to detect signs of Alzheimer's disease.

20 Mar 2008

Illicit drug use and risky sex fueling rise in syphilis

According to researchers in the U.S. syphilis which was almost eradicated a decade ago in the developed world, is making a comeback.

19 Mar 2008

1 in 6 women and 1 in 10 men at risk for Alzheimer's disease in their lifetime

Researchers from Boston University School of Medicine (BUSM) have estimated that one in six women are at risk for developing Alzheimer's disease (AD) in their lifetime, while the risk for men is one in ten.

19 Mar 2008

Lithium chloride slows development of inclusion body myositis

A new UC Irvine study finds that lithium chloride, a drug used to treat bipolar disorder, can slow the development of inclusion body myositis, a skeletal muscle disease that affects the elderly.

19 Mar 2008

White matter and balance in old age

New research shows how well people get around and keep their balance in old age is linked to the severity of changes happening in their brains.

18 Mar 2008

Wine harder on the brain than beer

Scientists say wine damages the brain more than beer or spirits, because it particularly affects the hippocampus, the part of the brain associated with memory and spatial awareness.

17 Mar 2008

Near-infrared light used to detect signs of Alzheimer's disease

A team of researchers in Bedford, Mass. has developed a way of examining brain tissue with near-infrared light to detect signs of Alzheimer's disease.

17 Mar 2008

Offspring of parents who both have Alzheimer's disease may be more likely to develop the illness

Adult-age offspring of parents who have both been diagnosed with Alzheimer's disease appear to have an increased risk of developing the disease compared with the general population, according to a report in the March issue of Archives of Neurology.

11 Mar 2008

Alzheimer's sufferers may benefit from cannabis compound

Scientists are suggesting that cannabis can offer some benefit for Alzheimer's sufferers.

11 Mar 2008

Paradoxical Alzheimer's finding may provide better understanding of memory loss

Do you remember the seventh song that played on your radio on the way to work yesterday?

10 Mar 2008

Cannabis-derived medicines may help Alzheimer's

Cannabis-derived medicines may one day be used in the treatment of Alzheimer's disease which affects 417,000 people in the UK.

10 Mar 2008

Neural progenitor cells as reservoirs for HIV in the brain

Impaired brain function is a prominent and still unsolved problem in AIDS.

6 Mar 2008

Dementia diagnosis brings relief, not depression

When it comes to a diagnosis of Alzheimer's disease, what you don't know may not kill you, but knowing the truth as soon as possible appears to be the better approach - one that may improve the emotional well-being of both patients and their caregivers, suggests new research from Washington University in St. Louis.

4 Mar 2008

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

1 Mar 2008